The primary reason these treatments are often inadequate is the heterogeneous nature of the disease, which involves multiple pathogenic pathways, including follicular occlusion, immune dysregulation, and genetic predisposition [6,7,8]
This reiterates that early comprehensive management of T2DM will reduce its high CV mortality, as reflected in the CAPTURE real-life study ( The metabolic control results can be analyzed by comparing the data with the pivotal studies
less research for telogen effluvium specifically, but biological plausibility is strong
Tng t GLP-1, cc cht ng vn th th GLP-1 (GLP-1RA) cng c th lin kt vi GLP-1R v ng vai tr nh GLP-1
Blood 81, 34043413
Cancer chemoprevention research with selenium in the post-SELECT era: promises and challenges